Growth Metrics

Bio-Techne (TECH) EBIT Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 12.69%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -347.04%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 80.62%
7 Evaxion A 62.56 Bn 62.54 Bn - 1.27%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,386.07%
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn 95.04%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 95.04%
Dec 31, 2025 14.85%
Sep 30, 2025 19.18%
Jun 30, 2025 -152.07%
Mar 31, 2025 -42.23%
Dec 31, 2024 24.77%
Sep 30, 2024 -28.42%
Jun 30, 2024 -51.52%
Mar 31, 2024 -16.47%
Dec 31, 2023 -44.02%
Sep 30, 2023 -0.81%
Jun 30, 2023 17.32%
Mar 31, 2023 -11.32%
Dec 31, 2022 8.89%
Sep 30, 2022 -10.92%
Jun 30, 2022 17.48%
Mar 31, 2022 31.80%
Dec 31, 2021 22.26%
Sep 30, 2021 28.78%
Jun 30, 2021 74.46%
Mar 31, 2021 43.60%
Dec 31, 2020 37.85%
Sep 30, 2020 47.30%
Jun 30, 2020 -9.14%
Mar 31, 2020 8.39%
Dec 31, 2019 10.09%
Sep 30, 2019 29.36%
Jun 30, 2019 0.81%
Mar 31, 2019 2.33%
Dec 31, 2018 39.15%
Sep 30, 2018 -1.03%
Jun 30, 2018 7.16%
Mar 31, 2018 28.60%
Dec 31, 2017 35.05%
Sep 30, 2017 -10.72%
Jun 30, 2017 0.08%
Mar 31, 2017 -23.03%
Dec 31, 2016 -50.37%
Sep 30, 2016 -6.03%
Jun 30, 2016 5.85%
Mar 31, 2016 10.40%
Dec 31, 2015 4.18%
Sep 30, 2015 -11.89%
Jun 30, 2015 -2.69%
Mar 31, 2015 -13.86%
Dec 31, 2014 -3.26%
Sep 30, 2014 -10.60%
Jun 30, 2014 162.23%
Mar 31, 2014 4.15%
Dec 31, 2013 -3.14%
Sep 30, 2013 4.20%
Jun 30, 2013 -251.44%
Mar 31, 2013 -5.21%
Dec 31, 2012 -2.06%
Sep 30, 2012 -7.68%
Jun 30, 2012 -3.25%
Mar 31, 2012 3.63%
Dec 31, 2011 0.89%
Sep 30, 2011 6.74%
Jun 30, 2011 168.00%
Mar 31, 2011 7.42%
Dec 31, 2010 2.18%
Sep 30, 2010 -2.14%